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Abstract Most Alzheimer’s disease (AD) cases are late-
onset and characterized by the aggregation and deposition
of the amyloid-beta (Ab) peptide in extracellular plaques
in the brain. However, a few rare and hereditary Ab
mutations, such as the Italian Glu22-to-Lys (E22K)
mutation, guarantee the development of early-onset
familial AD. This type of AD is associated with a younger
age at disease onset, increased b-amyloid accumulation,
and Ab deposition in cerebral blood vessel walls, giving
rise to cerebral amyloid angiopathy (CAA). It remains
largely unknown how the Italian mutation results in the
clinical phenotype that is characteristic of CAA. We
therefore investigated how this single point mutation may
affect the aggregation of Ab1–42 in vitro and structurally
characterized the resulting fibrils using a biophysical
approach. This paper reports that wild-type and Italian-
mutant Ab both form fibrils characterized by the cross-b
architecture, but with distinct b-sheet organizations,
resulting in differences in thioflavin T fluorescence and
solvent accessibility. E22K Ab1–42 oligomers and fibrils
both display an antiparallel b-sheet structure, in compar-
ison with the parallel b-sheet structure of wild-type fibrils,
characteristic of most amyloid fibrils described in the lit-
erature. Moreover, we demonstrate structural plasticity for
Italian-mutant Ab fibrils in a pH-dependent manner, in
terms of their underlying b-sheet arrangement. These
findings are of interest in the ongoing debate that (1)
antiparallel b-sheet structure might represent a signature
for toxicity, which could explain the higher toxicity
reported for the Italian mutant, and that (2) fibril poly-
morphism might underlie differences in disease pathology
and clinical manifestation.
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Abbreviations
AD Alzheimer’s disease
AFM Atomic force microscopy
ATR Attenuated total reflectance
Ab Amyloid-beta peptide
CAA Cerebral amyloid angiopathy
DMSO Dimethyl sulfoxide
ESI Electrospray ionization
FAD Familial Alzheimer’s disease
FTIR Fourier transform infrared
HDX Hydrogen/deuterium exchange
HFIP Hexafluoroisopropanol
MS Mass spectrometry
NMR Nuclear magnetic resonance
TBS Tris-buffered saline
TEM Transmission electron microscopy
ThT Thioflavin T
WT Wild type
Introduction
The conversion of native and functional peptides or pro-
teins into higher ordered, toxic aggregates, and eventually
to amyloid fibrils, is characteristic of many human pro-
teinopathies [1]. Amyloid fibrils deposit extra- or
intracellularly and are implicated in neurodegenerative
disorders and systemic amyloidoses [2]. The defining
molecular unit of these amyloid fibrils is the cross-b spine
that originates from extended b-sheets composed of b-
strands that are arranged perpendicular to the fiber axis [3].
Although the cross-b characteristic is a common struc-
tural feature, amyloid fibrils show a great structural variety
and can differ in their underlying structure, symmetry,
width, twist periodicity, and curvature [4–6]. This struc-
tural polymorphism can have several molecular origins.
First, fibril polymorphs can differ in the number of
protofilaments (the minimal fibrillar entities) [7]. Second,
distinct orientations and modes of association of protofil-
aments and patterns of inter-residue interactions determine
how protofilaments are oriented [8–11]. Third, variations in
the underlying protofilament substructure can contribute to
fibril polymorphism [12, 13]. Despite the highly conserved
arrangement of fibrils in a cross-b manner along the
elongation axis, fibrils can thus display considerable
heterogeneity and structural polymorphism.
The biological relevance of fibril polymorphism is not
yet fully understood, but it is notable that fibril polymor-
phism has been reported for several disease-related
proteins. Substantial evidence indicates that different fibril
morphologies exert different toxicities in vitro and could be
related to differences in disease pathology and progression
in vivo, or could underlie the preference of amyloid to
deposit in specific cellular locations (i.e., tropism) [13–23].
However, the link between fibril polymorphism and clini-
cal subtypes of amyloidoses is still lacking.
One of the disease-related proteins for which fibril
polymorphism has been reported is the amyloid-beta (Ab)
peptide [24]. The Ab peptide is one of the underlying
causes of Alzheimer’s disease (AD) [25, 26], inclusion
body myositis [27], dementia with Lewy bodies [28], and
cerebral amyloid angiopathy (CAA) [29–31]. Whereas Ab
in AD is primarily deposited in the brain parenchyma, and
CAA is related to cerebrovascular amyloid deposition. Ab
deposition in vessel walls makes them prone to rupture and
narrows their lumina to the point of occlusion, resulting in
secondary lesions associated with CAA, such as intrac-
erebral and subarachnoid bleeding, multiple infarcts, and
periventricular edema [32]. CAA is, however pathophysi-
ologically related to AD and found with high prevalence in
AD patients (80–90 %) [33].
CAA is a common clinical symptom of early-onset
familial AD (FAD), in which disease symptoms occur
earlier in life compared to the more prevalent sporadic,
late-onset AD [34]. Most mutations that are recognized to
cause FAD are concentrated in the amyloid precursor
protein (APP) either within or around the Ab domain.
Mutations clustering near the Ab N-terminus were shown
to alter Ab production and enhance the kinetic of fibril and
intermediate aggregate species formation [35, 36], while
mutations located at the Ab C-terminus were only shown to
affect the release of Ab by favoring acceleration of the
production [37–40]. Interestingly, mutations reported
within residues 21–23 of Ab are implicated in increasing
Ab production, enhancing Ab aggregation kinetic and/or
delaying Ab clearance [41–46].
Carriers of the Italian E22K [47], Iowa D23N [42], or
Dutch E22Q [48] Ab mutation predominantly display the
clinical phenotype characteristic of CAA. In contrast, the
Flemish A21G mutation results in both significant amyloid
accumulation in brain blood vessels and parenchymal amy-
loid plaques [44], whereas Arctic E22G carriers develop
progressive dementia, typical of AD, but without the severe
CAA that characterizes other mutations in this region [49].
In this study, we monitored the aggregation of wild-type
(WT) and Italian-mutant E22K Ab1–42 under different
experimental conditions, and structurally characterized the
resulting fibrils. We provide evidence that, under near-
physiological conditions, E22K Ab1–42 spontaneously
forms fibrils comprising stable antiparallel b-sheets, in
contrast to WT fibrils that are composed of parallel b-
sheets, similar to most amyloid fibrils described in the
literature [50]. Moreover, to the best of our knowledge, this
is the first experimental demonstration that the underlying
b-sheet arrangement of Italian-mutant Ab fibrils is altered
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upon a change in pH, and that inter-conversion of the
corresponding fibril polymorphs occurs.
These results are interesting in light of the emerging
view that (1) antiparallel b-sheet structure may be of
importance in the pathology of AD [5, 51], and that (2)
fibril polymorphism may be implicated in in vivo differ-
ences in terms of disease pathology and age of disease
onset. We suggest that the antiparallel b-sheet conforma-
tion of E22K Ab fibrils, and maybe other CAA-related Ab
peptides, predisposes them to mainly deposit in blood
vessel walls, resulting in CAA.
Materials and methods
Reagents and chemicals
WT Ab1–42 was purchased from American Peptide Co.
(Sunnyvale, CA, USA), and E22K and D23N Ab1–42 were
purchased from JPT (JPT Peptide Technologies, Germany).
Dimethyl sulfoxide (DMSO 99.9 % purity), hexafluoro-
propan-2-ol (HFIP), Thioflavin T (ThT), uranyl acetate,
and pepsin were obtained from Sigma-Aldrich (St. Louis,
MO, USA). Antibodies (6E10, 4G8, 12F4) were from
Covance (Emeryville, CA, USA). Horseradish peroxidase-
conjugated anti-mouse antibodies were purchased from
Millipore (Billerica, MA, USA). Supersignal West Pico
Chemiluminescent Substrate and ECL plus Western blot
detection system were obtained from Thermo Fisher Sci-
entific (Biotechnology, Rockford, IL, USA) and GE
Healthcare (Piscataway, NJ, USA), respectively.
Ab sample preparation
Ab peptides were dissolved in cold HFIP at a concentration
of 2 mg/mL and incubated at room temperature (25 C) for
1 h. HFIP was evaporated under nitrogen flow and residual
HFIP was removed under vacuum using a Speed Vac
(Thermo Savant). Prior to incubation, peptides were dis-
solved in DMSO at a final concentration of 5 mM and then
diluted to a final concentration of 100 lM in TBS (Tris-
buffered saline: 20 mM Tris/HCl, pH 7.4, 100 mM NaCl)
or in 10 mM HCl pH 2.0. Peptides were incubated at 37 C
under quiescent conditions. Fibrillar samples were cen-
trifuged for 30 min at 16,100g prior to analysis by Fourier
transform infrared (FTIR) spectroscopy and hydrogen/
deuterium exchange mass spectrometry (HDX-MS).
Transmission electron microscopy
Ab samples (5 lL of a 100 lM concentration) were adsorbed
to carbon-coated Formvar 400-mesh copper grids (Agar Sci-
entific) for 1 min. The grids were washed and stained with 1 %
(w/v) uranyl acetate. Samples were studied with a JEOL JEM-
1400 microscope (JEOL Ltd., Tokyo, Japan) at 80 kV. Trans-
mission electron microscopy (TEM) images are representative
of three independently prepared Ab solutions.
Atomic force microscopy
Atomic force microscopy (AFM) images were acquired
using a VEECO Dimension 3100 atomic force microscope
(Bruker), operated in tapping mode in air using silicon
cantilevers with a resonance frequency of 325 kHz, a
spring constant of 46 Nm-1, and a tip radius of 10 nm
(lMASCH, NSC15/no Al). Images were collected at a scan
rate of 1 Hz. Each fibrillar sample (5 lL of a 100 lM
concentration) was deposited for 15 min onto freshly
cleaved mica surfaces to enable adsorption. The samples
were rinsed with ultrapure water (5 9 200 lL) and left to
dry in air before imaging.
Dot blot analysis with Ab-region specific antibodies
Ab aggregation was monitored by spotting 1 lg of Ab onto
a nitrocellulose membrane at several incubation times. The
membranes were blocked for 1 h at 4 C in 5 % non-fat
dry milk in TBS-Tween 20 buffer and then incubated
(24 h, 4 C) with mouse monoclonal Ab-region specific
antibodies 6E10, 4G8, or 12F4 (all diluted 1:3000 in 0.5 %
non-fat dry milk in TBS-Tween 20 buffer). Horseradish
peroxidase-conjugated anti-mouse antibody (1:2000 in
0.5 % non-fat dry milk in TBS-Tween 20 buffer, 4 C, 1 h)
was used as secondary antibody. Detection was carried out
using the Supersignal West Pico Chemiluminescent Sub-
strate and the ECL Western blot kit. Images were
recorded and analyzed using the ImageQuant 400 gel
imager and ImageQuant TL software (GE Healthcare).
Secondary structure and HDX measurements using
ATR-FTIR spectroscopy
Attenuated total reflectance FTIR (ATR-FTIR) spectra
were recorded on an Equinox 55 IR spectrophotometer
(Bruker Optics, Ettlingen, Germany). A quantity of 2 lg of
Ab was spread on the diamond surface (2 9 2 mm) of the
internal reflection element and was washed with excess
milli-Q water to eliminate salts. Excess water was evapo-
rated under nitrogen flow. Each spectrum represents the
mean of 128 repetitions, recorded at a resolution of
2 cm-1. The ATR-FTIR data were analyzed using Kinetics
software (SFMB, Brussels, Belgium) and processed for
baseline correction and subtraction of the water vapor
contribution. Spectra were smoothed at a final resolution of
4 cm-1 by apodization of their Fourier transform by a
Gaussian line and intensities were normalized to the
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intensity of the major b-structure peak around 1630 cm-1.
All depicted spectra were deconvolved using a Lorentzian
deconvolution factor with a full width at half height
(FWHH) of 20 cm-1, a Gaussian apodization factor with
FWHH of 16.67 cm-1 to obtain a resolution enhancement
factor of 1.2. Deconvolution increases the resolution of the
spectra in the amide I region which is most sensitive to the
secondary structure of proteins. Next, curve fitting was
performed on the non-deconvolved ATR-FTIR spectra to
determine the secondary structure content of each sample.
The proportion of a particular structure is computed to be
the sum of the area of all the fitted bands (having their
maximum in the frequency region where that structure
occurs) divided by the area of all the Lorentzian bands
(having their maximum between 1700 and 1600 cm-1).
They were chosen by Kinetics software based on the shape
of the most deconvolved spectrum (a-helices and random
coil: 1637–1662 cm-1, turn: 1662–1682 cm-1, b-sheet:
1613–1637 cm-1, and 1682–1689 cm-1). Curve fitting has
a tendency to overestimate the b-sheet content. Combining
curve fitting analysis and hydrogen/deuterium exchange on
Ab fibrils (7 days) enhances the prediction of secondary
structure and allow us to determine exchange dynamics.
The decay of the NH-associated amide II band
(1520–1580 cm-1) was used to monitor the exchange of
the amide group. Results were analyzed as previously
described [52]. This information is of macroscopic nature
and is related to the compactness of the amyloid fold.
Thioflavin T fluorescence
Fibril formation was probed using ThT fluorescence as
described previously [53]. Briefly, 5 lM of ThT was
freshly dissolved in 50 mM glycine/NaOH pH 8.5 and
4.5 lg of Ab was added to 1 mL ThT solution. ThT fluo-
rescence emission was recorded between 460 and 560 nm
(excitation wavelength of 450 nm). All measurements were
recorded on a LS55 fluorimeter (PerkinElmer Instruments)
at 25 C with slit widths of 5 nm.
X-ray fiber diffraction
Ab fibrils (8 mg/mL) were aligned between wax-tipped
capillaries and allowed to air dry [54]. The partially aligned
fiber was placed on a goniometer head and data were
collected using a Rigaku rotating anode source (CuKa) and
Saturn 944? CCD detector. The diffraction patterns were
examined and measured using Clearer [55].
HDX-MS coupled to pepsin proteolysis
A volume of 25 lL of amyloid fibrils of WT and E22K
Ab1–42, grown for 21 days in TBS (100 lM monomeric
concentration), were collected by centrifugation at
16,100g for 30 min at 4 C. A volume of 24 lL of
supernatant was removed and the pellet was resuspended
with 24 lL D2O. Labeling was carried out for 15 min at
room temperature. Fibril samples were recovered by cen-
trifugation at 16,100g for 30 min at 4 C. Since then,
samples and solutions were held on ice. A volume of 24 lL
of D2O supernatant was removed and fibrils were dissolved
in 20.4 lL of 100:0.5 (v/v) H2O/HCOOH containing pep-
sin (1:5, enzyme/substrate, w/w). After 20 s, 3.6 lL of
100:0.5 (v/v) MeCN/HCOOH was added [85:15:0.5 (v/v/v)
H2O/MeCN/HCOOH final concentration] allowing fibril
dissolution [56].
For HDX on monomers of WT and E22K Ab1–42, the
dried peptides were first dissolved in DMSO at a concen-
tration of 2 mM and subsequently resuspended in D2O
(final concentration: 80 lM) and exchange was allowed for
45 min. One lL of the exchanged monomeric peptide was
added to 20.4 lL of 100:0.5 (v/v) H2O/HCOOH containing
pepsin (1:5, enzyme/substrate, w/w). After 20 s, 3.6 lL of
100:0.5 (v/v) MeCN/HCOOH was added [85:15:0.5 (v/v/v)
H2O/MeCN/HCOOH final concentration].
HDX was then evaluated by electrospray ionization
mass spectrometry (ESI–MS). The deuterium content of
the samples was analyzed by ESI–MS on a Q-TOF Ultima
API spectrometer (Waters/Micromass). Samples were
electrosprayed from gold-coated glass capillaries (Ther-
mo Fisher). Capillary and cone voltages applied were
1.8 kV and 50 V, respectively. The same dead time
(1 min) after mixing in protic solvent was used for all
experiments. All measurements were performed in tripli-
cate and mass spectra presented are averages of 20 s
acquisition.
The fraction of D2O in the pepsin solution, used for
monomeric and fibrillar samples, is 4 % (v/v) (1 lL D2O
for 24 lL H2O). The labile terminal and side chain
hydrogens exchange very rapidly even at pH 2.0–3.0, so
that the final measured deuterium content should include
an equilibrium distribution of deuterium into these sites.
Because there are 27 and 28 such hydrogens in WT and
E22K Ab1–42, respectively, a total of only one deuterium
atom (4 % of 27.5) should be incorporated at these sites
for full-length monomeric Ab and is thus not considered
here. The deuterium content of the peptides is deter-
mined from the centroid of the molecular ion isotope
peaks as described earlier [57]. The measured deuterium
content in each peptide is corrected for back exchange
(BE). Back exchange occurs during the pepsin processing
of samples in solvent that contains exchangeable
hydrogens, and during ionization itself, as previously
described [58].
Dcorr ¼ m MW þ BE
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BE ¼ MW þ Nm100%
Dcorr is the corrected average number of amide deuterons
after incubation in D2O, m is the measured centroid mass
after 45 min of labeling, MW is the measured average
molecular weight in H2O, N is the total number of amide
hydrogens in each peptide (exchangeable sites), and m100 %
is the measured centroid peptide mass from 100 %
deuteration controls. Monomeric Ab is expected to be fully
deuterated after only 30 min and is used as the control to
estimate the back exchange during the analysis. The back
exchange ranges from 12.5 to 37.8 % and is similar to
other studies [10, 59].
Results
E22K Ab1–42 forms fibrils with an antiparallel b-
sheet conformation
WT and E22K Ab1–42, of which the primary sequences are
displayed in Fig. 1a, were dissolved in 100 % HFIP to
ensure removal of pre-formed aggregates. After evapora-
tion of HFIP, the aggregation of Ab was induced by
dissolving the peptide film in DMSO at a concentration of
5 mM. Peptide samples were then diluted to a final con-
centration of 100 lM in TBS buffer of pH 7.4. The
emergence of heterogeneous oligomeric and prefibrillar
species, and subsequent fibril formation for both WT and
E22K Ab1–42 was confirmed by TEM (Fig. S1A). AFM,
being more sensitive for the detection of smaller Ab
aggregates (i.e., oligomers) than TEM [60], demonstrated
the fibril preparations to be virtually oligomer free
(Fig. S1B). Moreover, the accessibility of the C-terminus
of both peptides was lost upon aggregation as assessed by
dot blotting with region specific anti-Ab antibodies
(Fig. S2). This is in full agreement with previous nuclear
magnetic resonance (NMR) studies showing folding of the
C-terminus of the Ab1–42 peptide into the fibril core [17,
61].
To gain insight into the structural rearrangements
occurring during aggregation of the E22K Ab1–42 peptide
and into the differences with WT Ab1–42, we monitored the
Ab aggregation process using ATR-FTIR (Fig. 1b, c). The
amide I absorption band (1600–1700 cm-1) was used for
IR spectra analysis because this band results from C=O
stretching vibrations of peptide bonds and is most sensitive
to changes in the H-bonding and secondary structure in
proteins [52, 62]. Upon aggregation, WT and E22K Ab1–42
both displayed b-sheet structure, indicated by a major peak
around 1630 cm-1 (Fig. 1b, c). The position and width of
this peak have been related to the number of b-strands and/
or the formation of H-bonds [63–65]. Both peptides also
showed an additional minor peak around 1695 cm-1 at
early aggregation time points (0, 24 h). This peak, in
conjunction with the major peak, is the signature of an
antiparallel arrangement of b-strands [66–68] and can be
attributed to the presence of oligomers [69–72]. Mature
fibril formation was marked by a high b-sheet content for
both WT and E22K Ab1–42, as demonstrated by curve fit-
ting of the amide I region (Table 1). However, the
structural rearrangements occurring during the oligomer-
to-fibril transformation were different for WT and E22K
Ab1–42. As demonstrated previously, the oligomer-to-fibril
transformation of WT Ab1–42 was accompanied by a major
change in secondary structure [71]. The antiparallel con-
tribution associated with the minor peak around 1695 cm-1
disappeared when fibrils were formed (Fig. 1b), indicating
reorganization of b-strands from an antiparallel to a par-
allel orientation [71]. In contrast, in the case of E22K
Ab1–42, the 1695 cm
-1 peak persisted in time, suggesting
that Italian-mutant fibrils are mainly composed of
antiparallel b-sheets (Fig. 1c). The structural differences
occurring during aggregation were quantified by the b-in-
dex ratio (defined as the 1695/1630 cm-1 intensity ratio),
which has been shown to be proportional to the percentage
of antiparallel arrangement of b-strands in a b-sheet [66,
69, 71, 72]. The b-index ratio of WT Ab1–42 decreased
significantly during the oligomer-to-fibril transformation
(0.20 ± 0.01 to 0.03 ± 0.02 after 7 days), whereas the
E22K b-index ratio retained high values throughout
aggregation (0.21 ± 0.05 to 0.15 ± 0.03 after 7 days)
(Fig. 1d). High b-index values have been reported to be
characteristic for antiparallel b-structured proteins such as
avidin, concanavalin A, and bacterial outer membrane
porin F [69, 70]. These results suggest that, contrary to
most structures reported previously for amyloid fibrils,
Italian-mutant Ab1–42 fibrils display an antiparallel b-sheet
architecture.
To structurally characterize E22K and WT Ab1–42 fibrils
in more depth and to ensure samples were oligomer-free,
fibrillar samples (7 days) were centrifuged at 16,100g for
30 min and the fibril pellet was resuspended in water prior
to IR data collection. Dense amyloid networks with pro-
truding, negatively stained fibrils were visualized using
TEM for both fibril pellets (Fig. 2a). In contrast to WT
Ab1–42, the IR spectrum of the E22K Ab1–42 fibril pellet
still displayed the minor peak at 1695 cm-1 and a shift in
the amide II band region (1500–1600 cm-1) to lower
wavenumbers (Fig. 2b), features both corresponding to
antiparallel b-sheet structure [71]. As oligomers were
removed by the centrifugation procedure, this observation
provides evidence that the antiparallel structural signature
detected in the total aggregated E22K Ab1–42 sample after
7 days of incubation (Fig. 1c) is due to E22K Ab1–42 fib-
rils, as these are the main aggregation species at this time
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point. To validate this attribution, we recorded an IR
spectrum for the fibril pellet of Iowa D23N Ab1–42, shown
previously to form metastable fibrils composed of
antiparallel b-sheets [73], which presents identical IR
spectral features (Fig. 2b).
The distinct underlying conformations of WT and E22K
Ab1–42 fibrils were further marked by different sensitivities
for staining with ThT, a dye commonly used to detect
amyloid fibrils [53, 74]. Whereas WT Ab1–42 fibrils
displayed a high ThT fluorescence intensity, the ThT flu-
orescence of E22K Ab1–42 fibrils was significantly lower
(Figs. 1e, 2c). Lower levels of ThT fluorescence could be
indicative of a lower affinity of Italian-mutant fibrils for
ThT, as shown previously for the Japanese DE22-Ab1–39
mutant, and/or of less accessibility of the dye to potential
binding sites [75].
As neither ATR-FTIR nor ThT fluorescence spec-
troscopy provided information on the relative positioning
Fig. 1 The Italian Ab mutation induces formation of antiparallel b-
sheet fibrils. a WT and Italian-mutant Ab sequences. The replacement
of a Glu residue for a Lys at position 22 (E22K) in the Italian mutant
is indicated in red. b–e Aggregation of WT and E22K Ab1–42 peptide
in TBS pH 7.4 at 37 C was monitored for 7 days using b–d ATR-
FTIR and e ThT fluorescence. The amide I region (1700–1600 cm-1)
of the ATR-FTIR spectra of b WT and c E22K Ab1–42 are depicted
and vertical broken lines are shown at 1695 cm-1. Spectral intensities
were normalized to the intensity of the major contribution of b-
structure around 1630 cm-1. Spectra were vertically offset for better
visualization. Spectra were deconvolved using a Lorentzian
deconvolution factor with a FWHH of 20 cm-1 and a Gaussian
apodization factor with a FWHH of 16.67 cm-1 to obtain a resolution
enhancement factor K = 1.2. Spectra are representative of at least
three independent experiments. d The b-index ratio (1695/1630 cm-1
intensity ratio) was calculated on the basis of scaled ATR-FTIR
spectra. Means and error bars have been calculated on the basis of
three independent experiments. e ThT fluorescence emission at
485 nm (kex = 450 nm) was measured during aggregation. Intensity
was corrected for the ThT background. Means and error bars have
been calculated on the basis of three independent experiments
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in the three-dimensional space, we resorted to X-ray
diffraction. The latter revealed that both fibril types dis-
played meridional (4.7 A˚) and equatorial (9.6–9.7 A˚)
reflections, corresponding to the distance between b-
strands within one b-sheet, and to the distance between b-
sheets, respectively (Fig. 2d). These reflections are con-
sistent with the cross-b diffraction pattern that is
characteristic for amyloid fibrils [3]. However, the orien-
tation obtained was not sufficient to distinguish between
parallel and antiparallel fibril structures. Furthermore, it is
difficult to establish antiparallel b-sheet signatures from
X-ray fiber diffraction due to a systematic absence of even
numbered repeats arising from the 21 helix [76].
ATR-FTIR and fluorescence spectroscopy data indicate
that WT and E22K Ab1–42 fibrils contain different b-sheet
organizations. Further analysis was then performed to gain
more detailed understanding of their structural differences.
The central region is more exposed in E22K
than in WT Ab1–42 fibrils
HDX patterns of fibrils were measured using ATR-FTIR
spectroscopy to gain insight into the H-bonded b-sheet net-
work. Hydrogen atoms exchange most easily when not
involved in H-bonds and/or when they are not buried in the
fibril core. Estimates of the secondary structure contribu-
tions, based on the analysis of IR spectra (Fig. 2b), indicated
that E22K Ab1–42 fibrils contain slightly less b-sheet and
more intrinsic disorder and turn contributions compared to
WT fibrils (Table 1). Accordingly, E22K Ab1–42 fibrils
demonstrated a higher HDX ratio than WT fibrils: 50 (±5) %
of amide hydrogens were exchanged by deuterium compared
to 30 (±5) % for WT fibrils, during a time lapse of 1 h
(Table 1). The difference in total HDX between WT and
mutant fibrils corresponds to the backbone of eight amino
acids, but the specific region responsible for this difference
cannot be derived from this dataset.
To achieve more insight into regional structural differ-
ences, additional segmental exchange information of fibrils
was therefore revealed by HDX-MS coupled with pepsin
proteolysis (Fig. 3). We identified three proteolytic Ab
fragments comprising residues [1–42], covering the whole
sequence of the peptide. The mass spectra of the N-terminal
fragment [1–19] and C-terminal fragment [35–42] were
similar for both WT and E22K fibrils after HDX, indicating
no difference in deuterium incorporation in these regions
within the time frame of the exchange. In contrast, the mass
spectra for the fragment [20–42] showed that E22K Ab1–42
fibrils were more exchanged than WT fibrils in this region as
the increase in mass after deuteration was more pronounced.
The number of deuterium atoms incorporated in each Ab
fragment was measured and data were corrected for back
exchange. The corrected numbers of backbone amide pro-
tons exchanged after 45 min incubation in D2O are
summarized in Table 1. For both WT and E22K Ab1–42, the
N-terminal region [1–19] showed little protection (respec-
tively 22 and 20 %) in comparison to the C-terminal region
(respectively 67 and 56 %) which is in agreement with the
dot blotting results (Fig. S2) and data obtained by others
using NMR for WT Ab1–42 [17, 61]. The deuterium incor-
poration in regions [1–19, 35–42] showed no significant
difference, as qualitatively observed from the mass spectra
(Fig. 3). For peptide fragment [20–42], the solvent accessi-
bility data resulted in (9.6 ± 0.8) total exchanged amide
protons for E22K, which is significantly higher than the
value obtained for the WT peptide (7.3 ± 0.7). Assuming
Table 1 Distinct HDX and secondary structure contributions for WT and E22K Ab1–42 fibrils
ATR-FTIR HDX-MS coupled to pepsin proteolysis
Secondary
structure (%)
Exchanged amide
protons (%)
b-index
ratio
Pepsin-induced Ab
fragments
Exchanged amide
protons
Protected
NH/total
Protected NH/total
(%)
WT Ab1-42 fibrils
b-sheet 63 30 ± 5 0.07 [1–19] 14.0 ± 0.5 4/18 22
[20–42] 7.3 ± 0.7 14.7/22 67a-helix 11
[35–42] 3.1 ± 0.5 3.9/7 56Random
coil
7
Turn 19
E22K Ab1-42 fibrils
b-sheet 58 50 ± 5 0.19 [1–19] 14.3 ± 0.4 3.7/18 20
[20–42] 9.6 ± 0.8 12.4/22 56a-helix 5
[35–42] 3.4 ± 0.3 3.6/7 51Random
coil
11
Turn 26
HDX was determined using ATR-FTIR (during a time lapse of 1 h) and ESI–MS (during a time lapse of 45 min) coupled to pepsin proteolysis.
Secondary structure contributions were estimated using ATR-FTIR
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that there is no difference in labeling in peptide [35–42], the
difference in deuterium incorporation between WT and
E22K Ab1–42 fibrils can thus be localized to the central
region [20–34] of the peptide.
A change in pH reveals different b-sheet
conformations for E22K Ab1–42 fibrils
The antiparallel b-structured fibrils that have been recently
reported for the Iowa mutant D23N Ab1–40 peptide were
suggested to be thermodynamically metastable [73]. In con-
trast, Italian-mutant fibrils displayed a high b-index ratio for
several months that reached approximately 60 % of its orig-
inal value after 1 year of incubation under near-physiological
conditions (TBS pH 7.4), with the majority of the fibrils still
retaining the antiparallel b-sheet conformation (Fig. S3).
To gain more insight into the interactions that play a role
in antiparallel b-sheet formation, we studied the behavior of
E22K Ab1–42 under different experimental conditions.
Aggregation of E22K Ab1–42 was monitored at low pH
(10 mM HCl pH 2.0) at 37 C. It has been suggested that
WT Ab fibrils are stabilized by a salt bridge between D23
and K28 [13, 17], whereas a salt bridge between K22 and
D23 would be present in E22K Ab fibrils [77]. These salt
bridges would however not occur at low pH due to neu-
tralization of the negative charge of the D23 side chain
(pH\ pKa of Glu/Asp), and this might elicit structural
changes during the aggregation process. Accordingly, ATR-
FTIR analysis revealed a WT-like behavior for the aggre-
gation of the Italian mutant directly incubated at pH 2.0. The
b-index ratio decreased significantly from 0.12 ± 0.01 to
0.06 ± 0.02 during the time course of the experiment
Fig. 2 WT and E22K Ab1–42 fibrils display similar morphologies but
distinct underlying structures. WT and E22K Ab1–42 fibrils (depicted
in black and red, respectively) were structurally characterized after
7 days of incubation in TBS pH 7.4 at 37 C. a TEM revealed dense
networks of negatively stained fibrils for both fibril types. Scale bars
represent 500 nm. b ATR-FTIR spectra of E22K, D23N, and WT
Ab1–42 fibrils, harvested after 30 min of centrifugation at
16,100g. E22K and D23N fibrils displayed an additional peak around
1695 cm-1 (vertical dashed line) and a shift in the amide II band to
lower wavenumbers (as depicted by the arrows), indicative of an
underlying antiparallel b-sheet architecture, compared to the parallel
orientation of b-sheets in WT fibrils. Spectral intensities were
normalized to the intensity of the major contribution of b-structure
around 1630 cm-1. Spectra were vertically offset for better visual-
ization. Spectra were deconvolved using a Lorentzian deconvolution
factor with a FWHH of 20 cm-1 and a Gaussian apodization factor
with a FWHH of 16.67 cm-1 to obtain a resolution enhancement
factor K = 1.2. c ThT fluorescence emission spectra (kex = 450 nm)
corresponding to fibrils in b. E22K Ab1–42 fibrils showed low
reactivity with the fluorescent probe ThT, whereas WT fibrils induced
a high ThT fluorescence signal. Spectra were corrected for the ThT
background. d X-ray fiber diffraction resulted in the cross-b
reflections, characteristic of amyloid fibrils [54] for both fibril types
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(18 days), indicating a conversion from antiparallel oligo-
mers to parallel fibrils (Fig. 4). Hence, the E22K Ab peptide
evolves into the parallel b-sheet fibrillar state at low pH,
possibly due to alterations of electrostatic interactions.
Next, E22K antiparallel fibrils were first grown at neutral
pH (TBS pH 7.4) and 37 C, and the fibril pellet (obtained
after centrifugation for 30 min at 16,100g) was then redis-
solved in 10 mM HCl pH 2.0. This pH jump lead to a
significant decrease in the b-index ratio from 0.21 ± 0.01 to
0.08 ± 0.01, corresponding to parallel b-structured fibrils,
indicating that an antiparallel-to-parallel conversion occur-
red and demonstrating that the inter-conversion of fibril
polymorphs is possible. This decrease of the b-index ratio
occurred within the dead time of the experiment (*30 min).
Discussion
Amyloid oligomers have emerged as the culprit species
responsible for potent toxicity activities [78, 79]. However,
despite the amount of data published supporting their
role(s) in neuronal degeneration and cell death, the molec-
ular mechanism of toxicity is still puzzling [80]. Even so,
oligomers exist in equilibrium with fibrils and therefore the
kinetic, thermodynamic, and physiological factors affecting
the formation, metabolism, and activity of one of these
assemblies also affect the others. Ab fibrils are inherently
stable but are not inert and neither, non-toxic end product
deposits. Although the toxicity of oligomeric species is much
more pronounced [81, 82], Ab fibrils do have a significant
established effect on neuronal viability compared to unag-
gregated peptide [60]. By themselves, fibrils present direct
detrimental effects in particular contexts (e.g., obstructive
vascular amyloid, mechanical effect on membrane cells)
[83–85] and can induce a neuroinflammatory response trig-
gered by the activation of microglial cells [86] which is
currently thought to contribute to AD progress [87].
In this manuscript, we report that the E22K mutation of
Ab oligomers shows a similar antiparallel b-sheet struc-
tural arrangement which is retained upon fibril conversion.
This observation raises the question if indeed an antipar-
allel b-sheet can be regarded as a structural fingerprint for
toxicity. Interestingly, in the particular case of FAD-related
Ab1–42 mutants, in vitro studies have demonstrated that
neurotoxicity correlates well with the ability of these
peptides to aggregate [88, 89].
Antiparallel b-sheet structure: a key organization
in amyloid aggregates?
The impact of antiparallel b-sheet structure on amyloids is
still under debate, but evidence emerges that this structural
signature can be attributed to several higher toxicity
intermediates or off-pathway aggregates of the amyloid
Fig. 3 The central region is more exposed in E22K than in WT
Ab1–42 fibrils. Segmental HDX information of E22K and WT Ab1–42
fibrils was revealed by HDX-MS coupled with pepsin proteolysis.
Mass spectra corresponding to E22K and WT Ab1–42 fibrils are
displayed before (gray) and after (black) deuteration for 45 min. The
charge state of each fragment is indicated in each panel. The mass
spectra of the N-terminal fragment [1–19] and C-terminal fragment
[35–42] were very similar after deuteration for both WT and E22K
indicating no difference in deuterium incorporation in these regions.
Conversely the mass spectra for the fragment [20–42] showed more
exchange for E22K compared to WT Ab1–42, as seen by the more
pronounced mass increase after deuteration (indicated by arrows)
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formation pathway. Streltsov and co-workers [90] reported
the first crystal structure of oligomers of the p3 fragment,
the N-terminally truncated Ab variant, and provided evi-
dence for their antiparallel arrangement. Later, the research
team of Eisenberg revealed the structure of an off-pathway,
cylindrical oligomer of a segment of the amyloid-forming
protein aB-crystallin that resembled a b-barrel composed
of six antiparallel b-strands [51]. We and other groups
demonstrated that amyloidogenic proteins, such as Ab,
pass through an antiparallel b-sheet structured state, cor-
responding to oligomers, before undergoing a transition in
structure to parallel b-sheet fibrils [69–71, 91–93].
Recently, the group of Tycko demonstrated that Ab1–40
containing the Iowa D23N mutation, resulting in a pre-
dominant vascular phenotype, can assemble into
antiparallel b-sheet structured fibrils that are thermody-
namically metastable and have a ribbon-like appearance
[73]. As these aggregates were all described to be transient
and toxic, the antiparallel b-sheet arrangement has been
suggested to represent a unique toxic signature [72].
In this study, we report that an antiparallel b-sheet sig-
nature is shared by oligomers and fibrils comprising the
Italian-mutant E22K Ab1–42 peptide (Figs. 1, 2). The
antiparallel b-sheet fibrils are formed spontaneously under
near-physiological conditions and display a high b-index
ratio for at least 1 year (Fig. S3). The Italian-mutant Ab
peptide can thus potentially provide a major source of
neurotoxicity, either in the form of soluble and diffusible
oligomers that are considered the main toxic agents in AD
[79, 94, 95], or in its fibrillar form as a trigger of neu-
roinflammation [96]. One may speculate that, together with
the imbalance between the production and clearance of the
mutated peptide, this unique structural signature may be
linked to the early-onset and aggressive progression of the
associated FAD. Accordingly, the Italian Ab mutant shows
increased pathogenicity compared to the WT Ab peptide
and is up to tenfold more toxic to cerebrovascular smooth
muscle cells [97] and PC12 cells in vitro [88, 89], sup-
porting its role in CAA.
The Italian Ab mutant can form antiparallel
and parallel b-sheet fibrils
Amyloid fibrils share the cross-b spine motif, but their
quaternary arrangement can differ due to distinct non-polar
interactions; i.e., Van der Waals forces and aromatic pack-
ing, and polar interactions, i.e., electrostatic and H-bonding
interactions. It is conceivable that substitution of a glutamic
acid to a lysine at position 22 within the Ab sequence may
profoundly affect the pattern of interactions that determines
its fibrillar structure. The residue at position 22 is part of the
central Ab region that poses the critical limiting step leading
to the formation of the b-hairpin, the ordered b-turn-b
structural organization characteristic of Ab monomers
within the fibril [89, 98, 99]. Based on solid state NMR data,
Masuda and co-workers [77, 100] suggested previously that
intermolecular b-sheet contacts in E22K Ab1–42 fibrils are
key events driven by this turn region.
The results obtained at pH 7.4 give more insight into the
possible effects on the fibril structure due to the charge
alteration in this central Ab region. First, we demonstrate
that the E22K mutation results in differences in IR spectra
that reflect distinct H-bonding organizations of WT and
E22K Ab1–42 fibrils, i.e., parallel and antiparallel b-sheet
arrangements respectively. The differences in structure of
WT and E22K Ab1–42 fibrils were further marked by dif-
ferent ThT fluorescence intensities and HDX behaviors
(Figs. 1, 2, 3). Second, the E22K mutation most likely
induces changes in the pattern of stabilizing electrostatic
interactions, as it can interfere with salt bridges that have
Fig. 4 The b-sheet structure of Italian-mutant Ab1–42 fibrils is pH
sensitive. b-index ratios of E22K Ab1–42 obtained during aggregation
in TBS pH 7.4 (red curve) and 10 mM HCl pH 2.0 (green curve) at
37 C show that antiparallel b-sheet fibrils are formed at neutral pH
while parallel b-sheet fibrils are formed in acidic conditions.
Moreover, fibrils grown at neutral pH undergo a structural change
upon a shift to acidic pH (antiparallel-to-parallel transition) as seen by
the significant decrease in b-index ratio (gray curve)
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been suggested to occur within the monomeric unit of the
fibrillar structure, e.g., between D23 and K28 [13, 17], but
potentially also between K16 and E22 [13], and E22 and
K28 [101]. Differences in electrostatic interactions could
underlie the structural alterations demonstrated for E22K
fibrils at different pH values (Fig. 4). Third, the E22K
mutation may potentially influence conserved hydrophobic
contacts within the monomer unit composing the fibril,
e.g., between F19 and G38 [102], or affect the interdigi-
tation of b-sheets that is responsible for the steric zipper
interface underlying the cross b structure [1]. The steric
hindrance induced by the large side chain of K22 may
result in changes in the exposure of side chains to the outer
fibril surface and contribute to packing polymorphism.
Accordingly, the E22K mutation induced changes in sol-
vent accessibility around the central region, as assessed by
HDX measurements (Table 1; Fig. 3).
Furthermore, we provide evidence that structural alter-
ations occur for E22K Ab fibrils in different environmental
growing conditions. At neutral pH, the antiparallel b-sheet
fibrillar structure is favored. In contrast, the E22K Ab1–42
peptide forms fibrils with a parallel b-sheet arrangement at
low pH (Fig. 4). To the best of our knowledge, this is the
first experimental demonstration that a mutated form of the
full-length Ab peptide can form amyloid fibrils with two
different b-sheet structures in a pH-dependent manner.
This structural diversity might be due to neutralization of
charges of amino acid side chains involved in key fibril
contacts, as discussed in the previous section. Moreover,
our results show inter-conversion of antiparallel-to-parallel
b-sheet Italian-mutant fibrils when changing from neutral
to acidic pH conditions. Recently, Tycko and co-workers
[103] demonstrated the evolution of a mixture of two Ab
fibril polymorphs to the thermodynamically most stable
polymorph. It remains to be discovered whether the inter-
conversion of Italian-mutant fibril polymorphs demon-
strated in this work is due to internal structural
rearrangement, or whether the antiparallel b-sheet fibrils
are destabilized upon a decrease in pH and are rebuilt in a
parallel b-sheet arrangement.
A detailed molecular understanding of the intermolec-
ular interactions that dictate the quaternary structure of
Italian-mutant Ab is still lacking, but the results presented
here suggest that differences in the H-bonding pattern,
electrostatic interactions, and balance of multiple side
chain contacts may underlie fibril polymorphism for this
Ab mutant.
Pathophysiological relevance of different b-sheet
architectures
It has been suggested that Ab fibril polymorphism may
have biological significance. Fibril polymorphism could
underlie in vitro differences in neurotoxicity, or in vivo
differences in disease pathology and progression in dif-
ferent individuals/cell types and/or types of amyloidosis
(i.e., tropism) [13–23, 104]. Recently, the first detailed
look at the architecture of amyloid fibrils from patient
brains demonstrated that two AD patients with distinct
clinical histories possessed Ab fibrils with a different
underlying structure [16]. Moreover, Prusiner and co-
workers showed that mice inoculated with brain homo-
genates from an Arctic AD case exhibited a pathology that
could be distinguished from mice inoculated with Swedish
or sporadic AD samples. This was seen by differential
accumulation of Ab isoforms and distinct morphology of
cerebrovascular Ab deposition [105]. It now becomes
clear that several mutations in the central Ab region that
are associated with CAA, including the Italian E22K and
Iowa D23N mutations, can result in the formation of Ab
fibrils with an antiparallel b-sheet structure (Fig. 2b). This
unique structural signature might predispose them to
deposit in cerebral blood vessels, rather than mainly
accumulating in plaques, as seen for WT Ab. It remains to
be solved how these in vitro observations of structural
differences can translate into differences in vivo, but one
possibility might be through distinct interactions with
receptors responsible for Ab clearance across the blood–
brain barrier.
Conclusions
In conclusion, the Italian-mutant Ab peptide forms oligo-
mers and fibrils in vitro that share the antiparallel b-sheet
organization. Our results are particularly interesting in light
of the ongoing debate that suggests that the antiparallel b-
sheet signature might provide the potential detrimental
toxic effect of Ab. Moreover, this is the first study that
experimentally demonstrates structural plasticity for E22K
Ab fibrils. The structural differences of WT and E22K Ab
fibrils observed in vitro might be a direct implication for
their in vivo differences: WT and E22K Ab deposition in
extracellular plaques and cerebral blood vessel walls,
respectively, and therefore associated with late- and early-
onset AD, respectively.
Acknowledgments EH is supported by a FWO doctoral fellowship.
NvN is supported by the VIB and the Flemish Hercules Foundation.
KB is supported by a grant from the Internationale Stichting Alz-
heimer Onderzoek (ISAO), an Odysseus II award from FWO and a
UTWIST fellowship. RS and SD are postdoctoral researchers for the
National Fund for Scientific Research (F.R.S.-FNRS, Belgium), VR is
senior research associate for the National Fund for Scientific Research
(F.R.S.-FNRS, Belgium), and is supported by grants from the F.R.S.-
FNRS (Belgium), the SAO-FRA (Belgium), and the Foundation Van
Buuren (Belgium).
Two distinct b-sheet structures in Italian mutant amyloid-beta fibrils: a potential link to… 4909
123
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted
use, distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were
made.
References
1. Eisenberg D, Jucker M (2012) The amyloid state of proteins in
human diseases. Cell 148:1188–1203
2. Chiti F, Dobson CM (2006) Protein misfolding, functional
amyloid, and human disease. Annu Rev Biochem 75:333–366
3. Sunde M, Serpell LC, Bartlam M, Fraser PE, Pepys MB, Blake
CC (1997) Common core structure of amyloid fibrils by syn-
chrotron X-ray diffraction. J Mol Biol 273:729–739
4. Fa¨ndrich M, Meinhardt J, Grigorieff N (2009) Structural polymor-
phism of Alzheimer Abeta and other amyloid fibrils. Prion 3:89–93
5. Tycko R, Wickner RB (2013) Molecular structures of amyloid
and prion fibrils: consensus versus controversy. Acc Chem Res
46:1487–1496
6. Ha¨rd T (2014) Amyloid fibrils: formation, polymorphism, and
inhibition. J Phys Chem Lett 5:607–614
7. Goldsbury CS, Frey P, Olivieri V, Aebi U, Mu¨ller SA (2005)
Multiple assembly pathways underlie amyloid-beta fibril poly-
morphisms. J Mol Biol 352:282–298
8. Petkova AT, Ishii Y, Balbach JJ, Antzutkin ON, Leapman RD,
Delaglio F, Tycko R (2002) A structural model for Alzheimer’s
beta-amyloid fibrils based on experimental constraints from
solid state NMR. Proc Natl Acad Sci USA 99:16742–16747
9. Petkova AT, Yau WM, Tycko R (2006) Experimental con-
straints on quaternary structure in Alzheimer’s beta-amyloid
fibrils. Biochemistry 45:498–512
10. Zhang A, Qi W, Good TA, Fernandez EJ (2009) Structural
differences between Abeta(1–40) intermediate oligomers and
fibrils elucidated by proteolytic fragmentation and hydrogen/
deuterium exchange. Biophys J 96:1091–1104
11. Sachse C, Fa¨ndrich M, Grigorieff N (2008) Paired beta-sheet
structure of an Abeta(1–40) amyloid fibril revealed by electron
microscopy. Proc Natl Acad Sci USA 105:7462–7466
12. Paravastu AK, Leapman RD, Yau WM, Tycko R (2008)
Molecular structural basis for polymorphism in Alzheimer’s
beta-amyloid fibrils. Proc Natl Acad Sci USA 105:18349–18354
13. Petkova AT, Leapman RD, Guo Z, Yau WM, Mattson MP,
Tycko R (2005) Self-propagating, molecular-level polymor-
phism in Alzheimer’s beta-amyloid fibrils. Science 307:262–265
14. Bousset L, Pieri L, Ruiz-Arlandis G, Gath J, Jensen PH,
Habenstein B, Madiona K, Olieric V, Bo¨ckmann A, Meier BH,
Melki R (2013) Structural and functional characterization of two
alpha-synuclein strains. Nat Commun 4:2575
15. Guo JL, Covell DJ, Daniels JP, Iba M, Stieber A, Zhang B,
Riddle DM, Kwong LK, Xu Y, Trojanowski JQ, Lee VM (2013)
Distinct a-synuclein strains differentially promote tau inclusions
in neurons. Cell 154:103–117
16. Lu JX, Qiang W, Yau WM, Schwieters CD, Meredith SC, Tycko
R (2013) Molecular structure of b-amyloid fibrils in Alzheimer’s
disease brain tissue. Cell 154:1257–1268
17. Luhrs T, Ritter C, Adrian M, Riek-Loher D, Bohrmann B, Dobeli H,
Schubert D, Riek R (2005) 3D structure of Alzheimer’s amyloid-
beta(1–42) fibrils. Proc Natl Acad Sci USA 102:17342–17347
18. Mocanu MM, Ganea C, Siposova K, Filippi A, Demjen E,
Marek J, Bednarikova Z, Antosova A, Baran I, Gazova Z (2014)
Polymorphism of hen egg white lysozyme amyloid fibrils
influences the cytotoxicity in LLC-PK1 epithelial kidney cells.
Int J Biol Macromol 65:176–187
19. Nekooki-Machida Y, Kurosawa M, Nukina N, Ito K, Oda T,
Tanaka M (2009) Distinct conformations of in vitro and in vivo
amyloids of huntingtin-exon1 show different cytotoxicity. Proc
Natl Acad Sci USA 106:9679–9684
20. Gath J, Bousset L, Habenstein B, Melki R, Bo¨ckmann A, Meier
BH (2014) Unlike twins: an NMR comparison of two a-synuclein
polymorphs featuring different toxicity. PLoS One 9:e90659
21. Fukunaga S, Ueno H, Yamaguchi T, Yano Y, Hoshino M,
Matsuzaki K (2012) GM1 cluster mediates formation of toxic
Abeta fibrils by providing hydrophobic environments. Bio-
chemistry 51:8125–8131
22. Seilheimer B, Bohrmann B, Bondolfi L, Mu¨ller F, Stu¨ber D,
Do¨beli H (1997) The toxicity of the Alzheimer’s beta-amyloid
peptide correlates with a distinct fiber morphology. J Struct Biol
119:59–71
23. Bergstro¨m J, Gustavsson A, Hellman U, Sletten K, Murphy CL,
Weiss DT, Solomon A, Olofsson BO, Westermark P (2005)
Amyloid deposits in transthyretin-derived amyloidosis: cleaved
transthyretin is associated with distinct amyloid morphology.
J Pathol 206:224–232
24. Fa¨ndrich M, Schmidt M, Grigorieff N (2011) Recent progress in
understanding Alzheimer’s b-amyloid structures. Trends Bio-
chem Sci 36:338–345
25. Glenner GG, Wong CW (1984) Alzheimer’s disease: initial
report of the purification and characterization of a novel cere-
brovascular amyloid protein. Biochem Biophys Res Commun
120:885–890
26. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald
BL, Beyreuther K (1985) Amyloid plaque core protein in Alz-
heimer disease and Down syndrome. Proc Natl Acad Sci USA
82:4245–4249
27. Askanas V, Bornemann A, Engel WK (1990) Immunocyto-
chemical localization of desmin at human neuromuscular
junctions. Neurology 40:949–953
28. Haltia M, Ghiso J, Wisniewski T, Kiuru S, Miller D, Frangione
B (1991) Gelsolin variant and beta-amyloid co-occur in a case of
Alzheimer’s with Lewy bodies. Neurobiol Aging 12:313–316
29. Attems J, Lintner F, Jellinger KA (2004) Amyloid beta peptide
1–42 highly correlates with capillary cerebral amyloid angiopathy
and Alzheimer disease pathology. Acta Neuropathol 107:283–291
30. Prelli F, Castan˜o E, Glenner GG, Frangione B (1988) Differ-
ences between vascular and plaque core amyloid in Alzheimer’s
disease. J Neurochem 51:648–651
31. Yamaguchi H, Hirai S, Morimatsu M, Shoji M, Ihara Y (1988)
A variety of cerebral amyloid deposits in the brains of the
Alzheimer-type dementia demonstrated by beta protein
immunostaining. Acta Neuropathol 76:541–549
32. Tian J, Shi J, Mann DM (2004) Cerebral amyloid angiopathy
and dementia. Panminerva Med 46:253–264
33. Ellis RJ, Olichney JM, Thal LJ, Mirra SS, Morris JC, Beekly D,
Heyman A (1996) Cerebral amyloid angiopathy in the brains of
patients with Alzheimer’s disease: the CERAD experience, Part
XV. Neurology 46:1592–1596
34. Yamada M (2012) Predicting cerebral amyloid angiopathy-re-
lated intracerebral hemorrhages and other cerebrovascular
disorders in Alzheimer’s disease. Front Neurol 3:64
35. Hori Y, Hashimoto T, Wakutani Y, Urakami K, Nakashima K,
Condron MM, Tsubuki S, Saido TC, Teplow DB, Iwatsubo T
(2007) The Tottori (D7N) and English (H6R) familial Alzheimer
disease mutations accelerate Abeta fibril formation without
increasing protofibril formation. J Biol Chem 282:4916–4923
36. Felsenstein KM, Hunihan LW, Roberts SB (1994) Altered
cleavage and secretion of a recombinant beta-APP bearing the
4910 E. Hubin et al.
123
Swedish familial Alzheimer’s disease mutation. Nat Genet
6:251–255
37. Maruyama K, Tomita T, Shinozaki K, Kume H, Asada H, Saido
TC, Ishiura S, Iwatsubo T, Obata K (1996) Familial Alzheimer’s
disease-linked mutations at Val717 of amyloid precursor protein
are specific for the increased secretion of Abeta 42(43). Bio-
chem Biophys Res Commun 227:730–735
38. Ancolio K, Dumanchin C, Barelli H, Warter JM, Brice A,
Campion D, Frebourg T, Checler F (1999) Unusual phenotypic
alteration of beta amyloid precursor protein (betaAPP) matura-
tion by a new Val-715 ? Met betaAPP-770 mutation
responsible for probable early-onset Alzheimer’s disease. Proc
Natl Acad Sci USA 96:4119–4124
39. Suzuki N, Cheung TT, Cai XD, Odaka A, Otvos L, Eckman C,
Golde TE, Younkin SG (1994) An increased percentage of long
amyloid beta protein secreted by familial amyloid beta protein
precursor (beta APP717) mutants. Science 264:1336–1340
40. Zhou L, Brouwers N, Benilova I, Vandersteen A, Mercken M,
Van Laere K, Van Damme P, Demedts D, Van Leuven F,
Sleegers K, Broersen K, Van Broeckhoven C, Vandenberghe R,
De Strooper B (2011) Amyloid precursor protein mutation
E682K at the alternative b-secretase cleavage b-site increases
Ab generation. EMBO Mol Med 3:291–302
41. Vandersteen A, Masman MF, De Baets G, Jonckheere W, van
der Werf K, Marrink SJ, Rozenski J, Benilova I, De Strooper B,
Subramaniam V, Schymkowitz J, Rousseau F, Broersen K
(2012) Molecular plasticity regulates oligomerization and
cytotoxicity of the multipeptide-length amyloid-b peptide pool.
J Biol Chem 287:36732–36743
42. Grabowski TJ, Cho HS, Vonsattel JP, Rebeck GW, Greenberg
SM (2001) Novel amyloid precursor protein mutation in an Iowa
family with dementia and severe cerebral amyloid angiopathy.
Ann Neurol 49:697–705
43. Natte´ R, Maat-Schieman ML, Haan J, Bornebroek M, Roos RA,
van Duinen SG (2001) Dementia in hereditary cerebral hemor-
rhage with amyloidosis-Dutch type is associated with cerebral
amyloid angiopathy but is independent of plaques and neu-
rofibrillary tangles. Ann Neurol 50:765–772
44. Hendriks L, van Duijn CM, Cras P, Cruts M, Van Hul W, van
Harskamp F, Warren A, McInnis MG, Antonarakis SE, Martin
JJ (1992) Presenile dementia and cerebral haemorrhage linked to
a mutation at codon 692 of the beta-amyloid precursor protein
gene. Nat Genet 1:218–221
45. Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron
MM, Axelman K, Forsell C, Stenh C, Luthman J, Teplow DB,
Younkin SG, Naslund J, Lannfelt L (2001) The ‘Arctic’ APP
mutation (E693G) causes Alzheimer’s disease by enhanced
Abeta protofibril formation. Nat Neurosci 4:887–893
46. Cheng IH, Palop JJ, Esposito LA, Bien-Ly N, Yan F, Mucke L
(2004) Aggressive amyloidosis in mice expressing human
amyloid peptides with the Arctic mutation. Nat Med
10:1190–1192
47. Bugiani O, Giaccone G, Rossi G, Mangieri M, Capobianco R,
Morbin M, Mazzoleni G, Cupidi C, Marcon G, Giovagnoli A,
Bizzi A, Di Fede G, Puoti G, Carella F, Salmaggi A, Romorini
A, Patruno GM, Magoni M, Padovani A, Tagliavini F (2010)
Hereditary cerebral hemorrhage with amyloidosis associated
with the E693K mutation of APP. Arch Neurol 67:987–995
48. Levy E, Carman MD, Fernandez-Madrid IJ, Power MD,
Lieberburg I, van Duinen SG, Bots GT, Luyendijk W, Frangione
B (1990) Mutation of the Alzheimer’s disease amyloid gene in
hereditary cerebral hemorrhage, Dutch type. Science
248:1124–1126
49. Kamino K, Orr HT, Payami H, Wijsman EM, Alonso ME, Pulst
SM, Anderson L, O’dahl S, Nemens E, White JA (1992) Linkage
and mutational analysis of familial Alzheimer disease kindreds for
the APP gene region. Am J Hum Genet 51:998–1014
50. Eichner T, Radford SE (2011) A diversity of assembly mecha-
nisms of a generic amyloid fold. Mol Cell 43:8–18
51. Laganowsky A, Liu C, Sawaya MR, Whitelegge JP, Park J,
Zhao M, Pensalfini A, Soriaga AB, Landau M, Teng PK, Cascio
D, Glabe C, Eisenberg D (2012) Atomic view of a toxic amyloid
small oligomer. Science 335:1228–1231
52. Goormaghtigh E, Raussens V, Ruysschaert JM (1999) Atten-
uated total reflection infrared spectroscopy of proteins and
lipids in biological membranes. Biochim Biophys Acta
1422:105–185
53. LeVine H 3rd (1999) Quantification of beta-sheet amyloid fibril
structures with thioflavin T. Method Enzymol 309:274–284
54. Morris KL, Serpell LC (2012) X-ray fibre diffraction studies of
amyloid fibrils. Method Mol Biol 849:121–135
55. Makin O, Sikorski P, Serpell L (2007) CLEARER: a new tool
for the analysis of X-ray fibre diffraction patterns and diffraction
simulation from atomic structural models. Appl Cryst
40:966–972
56. Kheterpal I, Wetzel R (2006) Hydrogen/deuterium exchange
mass spectrometry—a window into amyloid structure. Acc
Chem Res 39:584–593
57. Pan J, Han J, Borchers CH, Konermann L (2011) Conformer-
specific hydrogen exchange analysis of Abeta(1–42) oligomers
by top-down electron capture dissociation mass spectrometry.
Anal Chem 83:5386–5393
58. Kheterpal I, Wetzel R, Cook KD (2003) Enhanced correction
methods for hydrogen exchange-mass spectrometric studies of
amyloid fibrils. Protein Sci 12:635–643
59. Kheterpal I, Chen M, Cook KD, Wetzel R (2006) Structural
differences in Abeta amyloid protofibrils and fibrils mapped by
hydrogen exchange–mass spectrometry with on-line proteolytic
fragmentation. J Mol Biol 361:785–795
60. Dahlgren KN, Manelli AM, Stine WB, Baker LK, Krafft GA,
LaDu MJ (2002) Oligomeric and fibrillar species of amyloid-
beta peptides differentially affect neuronal viability. J Biol
Chem 277:32046–32053
61. Olofsson A, Sauer-Eriksson AE, Ohman A (2006) The solvent
protection of alzheimer amyloid-beta-(1–42) fibrils as deter-
mined by solution NMR spectroscopy. J Biol Chem
281:477–483
62. Oberg KA, Ruysschaert JM, Goormaghtigh E (2004) The opti-
mization of protein secondary structure determination with
infrared and circular dichroism spectra. Eur J Biochem
271:2937–2948
63. Kubelka J, Keiderling TA (2001) Differentiation of beta-sheet-
forming structures: ab initio-based simulations of IR absorption
and vibrational CD for model peptide and protein beta-sheets.
J Am Chem Soc 123:12048–12058
64. Zandomeneghi G, Krebs MRH, Mccammon MG, Fandrich M
(2004) FTIR reveals structural differences between native beta-
sheet proteins and amyloid fibrils. Protein Sci 13:3314–3321
65. Moran SD, Zanni MT (2014) How to get insight into amyloid
structure and formation from infrared spectroscopy. J Phys
Chem Lett 5:1984–1993
66. Chirgadze YN, Nevskaya NA (1976) Infrared spectra and res-
onance interaction of amide-I vibration of the antiparallel-chain
pleated sheet. Biopolymers 15:607–625
67. Krimm S, Bandekar J (1986) Vibrational spectroscopy and
conformation of peptides, polypeptides, and proteins. Adv Pro-
tein Chem 38:181–364
68. Miyazawa T, Blout ER (1961) Infrared spectra of polypeptides
in various conformations—amide I and II bands. J Am Chem
Soc 83:712–1000
Two distinct b-sheet structures in Italian mutant amyloid-beta fibrils: a potential link to… 4911
123
69. Celej MS, Sarroukh R, Goormaghtigh E, Fidelio GD, Ruyss-
chaert JM, Raussens V (2012) Toxic prefibrillar a-synuclein
amyloid oligomers adopt a distinctive antiparallel b-sheet
structure. Biochem J 443:719–726
70. Cerf E, Sarroukh R, Tamamizu-Kato S, Breydo L, Derclaye S,
Dufreˆne YF, Narayanaswami V, Goormaghtigh E, Ruysschaert
JM, Raussens V (2009) Antiparallel beta-sheet: a signature
structure of the oligomeric amyloid beta-peptide. Biochem J
421:415–423
71. Sarroukh R, Cerf E, Derclaye S, Dufreˆne YF, Goormaghtigh E,
Ruysschaert JM, Raussens V (2011) Transformation of amyloid
b(1–40) oligomers into fibrils is characterized by a major change
in secondary structure. Cell Mol Life Sci 68:1429–1438
72. Sarroukh R, Goormaghtigh E, Ruysschaert JM, Raussens V
(2013) ATR-FTIR: a ‘‘rejuvenated’’ tool to investigate amyloid
proteins. Biochim Biophys Acta 1828:2328–2338
73. Qiang W, Yau WM, Luo Y, Mattson MP, Tycko R (2012)
Antiparallel b-sheet architecture in Iowa-mutant b-amyloid
fibrils. Proc Natl Acad Sci USA 109:4443–4448
74. Biancalana M, Koide S (2010) Molecular mechanism of Thio-
flavin-T binding to amyloid fibrils. Biochim Biophys Acta
1804:1405–1412
75. Cloe AL, Orgel JP, Sachleben JR, Tycko R, Meredith SC (2011)
The Japanese mutant Ab (DE22-Ab(1–39)) forms fibrils
instantaneously, with low-thioflavin T fluorescence: seeding of
wild-type Ab(1–40) into atypical fibrils by DE22-Ab(1–39).
Biochemistry 50:2026–2039
76. Sikorski P, Atkins ED, Serpell LC (2003) Structure and texture
of fibrous crystals formed by Alzheimer’s Abeta(11–25) peptide
fragment. Structure 11:915–926
77. Masuda Y, Irie K, Murakami K, Ohigashi H, Ohashi R, Take-
goshi K, Shimizu T, Shirasawa T (2005) Verification of the turn
at positions 22 and 23 of the beta-amyloid fibrils with Italian
mutation using solid-state NMR. Bioorg Med Chem
13:6803–6809
78. Broersen K, Rousseau F, Schymkowitz J (2010) The culprit
behind amyloid beta peptide related neurotoxicity in Alzhei-
mer’s disease: oligomer size or conformation? Alzheimers Res
Ther 2:12
79. Benilova I, Karran E, De Strooper B (2012) The toxic Ab oli-
gomer and Alzheimer’s disease: an emperor in need of clothes.
Nat Neurosci 15:349–357
80. Kayed R, Lasagna-Reeves CA (2013) Molecular mechanisms of
amyloid oligomers toxicity. J Alzheimers Dis 33(Suppl 1):S67–
S78
81. Bitan G, Lomakin A, Teplow DB (2001) Amyloid beta-protein
oligomerization: prenucleation interactions revealed by photo-
induced cross-linking of unmodified proteins. J Biol Chem
276:35176–35184
82. Bitan G, Kirkitadze MD, Lomakin A, Vollers SS, Benedek GB,
Teplow DB (2003) Amyloid beta-protein (Abeta) assembly:
Abeta 40 and Abeta 42 oligomerize through distinct pathways.
Proc Natl Acad Sci USA 100:330–335
83. Qiang W, Yau WM, Schulte J Fibrillation of b amyloid peptides
in the presence of phospholipid bilayers and the consequent
membrane disruption. Biochim Biophys Acta 1848:266–276
84. Canale C, Seghezza S, Vilasi S, Carrotta R, Bulone D, Diaspro
A, San Biagio PL, Dante S Different effects of Alzheimer’s
peptide Ab(1–40) oligomers and fibrils on supported lipid
membranes. Biophys Chem 182:23–29
85. Cecchi C, Stefani M The amyloid-cell membrane system. The
interplay between the biophysical features of oligomers/fibrils
and cell membrane defines amyloid toxicity. Biophys Chem
182:30–43
86. Doens D, Fernandez PL Microglia receptors and their implica-
tions in the response to amyloid b for Alzheimer’s disease
pathogenesis. J Neuroinflammation 11:48
87. Heneka MT, Golenbock DT, Latz E Innate immunity in Alz-
heimer’s disease. Nat Immunol 16:229–236
88. Murakami K, Irie K, Morimoto A, Ohigashi H, Shindo M,
Nagao M, Shimizu T, Shirasawa T (2002) Synthesis, aggrega-
tion, neurotoxicity, and secondary structure of various Abeta
1–42 mutants of familial Alzheimer’s disease at positions
21–23. Biochem Biophys Res Commun 294:5–10
89. Murakami K, Irie K, Morimoto A, Ohigashi H, Shindo M,
Nagao M, Shimizu T, Shirasawa T (2003) Neurotoxicity and
physicochemical properties of Abeta mutant peptides from
cerebral amyloid angiopathy: implication for the pathogenesis of
cerebral amyloid angiopathy and Alzheimer’s disease. J Biol
Chem 278:46179–46187
90. Streltsov VA, Varghese JN, Masters CL, Nuttall SD (2011)
Crystal structure of the amyloid-b p3 fragment provides a model
for oligomer formation in Alzheimer’s disease. J Neurosci
31:1419–1426
91. Gu L, Liu C, Guo Z (2013) Structural insights into Ab42 oli-
gomers using site-directed spin labeling. J Biol Chem
288:18673–18683
92. Sandberg A, Luheshi LM, So¨llvander S, Pereira de Barros T,
Macao B, Knowles TP, Biversta˚l H, Lendel C, Ekholm-Petter-
son F, Dubnovitsky A, Lannfelt L, Dobson CM, Ha¨rd T (2010)
Stabilization of neurotoxic Alzheimer amyloid-beta oligomers
by protein engineering. Proc Natl Acad Sci USA
107:15595–15600
93. Zou Y, Li Y, Hao W, Hu X, Ma G (2013) Parallel b-sheet fibril
and antiparallel b-sheet oligomer: new insights into amyloid
formation of hen egg white lysozyme under heat and acidic
condition from FTIR spectroscopy. J Phys Chem B
117:4003–4013
94. Drachman DA (2014) The amyloid hypothesis, time to move on:
amyloid is the downstream result, not cause, of Alzheimer’s
disease. Alzheimers Dement 10:372–380
95. LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloid-
beta in Alzheimer’s disease. Nat Rev Neurosci 8:499–509
96. Rubio-Perez JM, Morillas-Ruiz JM (2012) A review: inflam-
matory process in Alzheimer’s disease, role of cytokines. Sci
World J 2012:756357
97. Melchor JP, McVoy L, Van Nostrand WE (2000) Charge
alterations of E22 enhance the pathogenic properties of the
amyloid beta-protein. J Neurochem 74:2209–2212
98. Doran TM, Anderson EA, Latchney SE, Opanashuk LA, Nilsson
BL (2012) Turn nucleation perturbs amyloid b self-assembly
and cytotoxicity. J Mol Biol 421:315–328
99. Pera´lvarez-Marı´n A, Mateos L, Zhang C, Singh S, Cedazo-
Mı´nguez A, Visa N, Morozova-Roche L, Gra¨slund A, Barth A
(2009) Influence of residue 22 on the folding, aggregation pro-
file, and toxicity of the Alzheimer’s amyloid beta peptide.
Biophys J 97:277–285
100. Masuda Y, Uemura S, Ohashi R, Nakanishi A, Takegoshi K,
Shimizu T, Shirasawa T, Irie K (2009) Identification of physi-
ological and toxic conformations in Abeta42 aggregates.
ChemBioChem 10:287–295
101. Lin YS, Pande VS (2012) Effects of familial mutations on the
monomer structure of Ab42. Biophys J 103:L47–L49
102. Ahmed M, Davis J, Aucoin D, Sato T, Ahuja S, Aimoto S,
Elliott JI, Van Nostrand WE, Smith SO (2010) Structural con-
version of neurotoxic amyloid-beta(1–42) oligomers to fibrils.
Nat Struct Mol Biol 17:561–567
4912 E. Hubin et al.
123
103. Qiang W, Kelley K, Tycko R (2013) Polymorph-specific
kinetics and thermodynamics of b-amyloid fibril growth. J Am
Chem Soc 135:6860–6871
104. Ihse E, Ybo A, Suhr O, Lindqvist P, Backman C, Westermark P
(2008) Amyloid fibril composition is related to the phenotype of
hereditary transthyretin V30M amyloidosis. J Pathol
216:253–261
105. Watts JC, Condello C, Sto¨hr J, Oehler A, Lee J, DeArmond SJ,
Lannfelt L, Ingelsson M, Giles K, Prusiner SB (2014) Serial
propagation of distinct strains of Ab prions from Alzheimer’s
disease patients. Proc Natl Acad Sci USA
Two distinct b-sheet structures in Italian mutant amyloid-beta fibrils: a potential link to… 4913
123
